Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Fund Letter | Gabriel RadzyminskiSandon Capital | Investment Banking & BrokerageCapital Markets | Long COG.AX (COG Financial Services Ltd) The largest positive contributors were COG Financial Services Ltd (COG) (+4.5%) and BCI Minerals Ltd (BCI) (+2.8%). These were partly... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Mike Collins, Matt Clarke, Chase McIntosh, Carl WieseGROW Funds | Alpha Cognition Inc. $ACOG• NASDAQ | -- | Long ACOG (Alpha Cognition Inc.) Lead drug ZUNVEYL was FDA approved in July 2024 for Alzheimer's treatment. It is only... | BULL | View Pitch → |
| Aug 21, 2026 | Fund Letter | Gabriel RadzyminskiSandon Capital | Investment Banking & BrokerageCapital Markets | Long COG.AX (COG Financial Services Ltd) COG announced significant changes at Board level with Patrick Tuttle, Stephen White and Mark Crain resigning as directors and Cameron McCullagh moving from an executive to a non-executive director role. Joining the Board... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Gabriel RadzyminskiSandon Capital | -- | Sandon Capital 2025 Q3 (COG) COG Financial Services was the largest positive contributor in September. The firm announced... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.